Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: What do we know so far?

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Haddad, Rodrigo ^a   Saldanha Araujo, Felipe ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ADENOSINE A2A RECEPTOR; B7 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GALECTIN 1; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEME OXYGENASE 1; INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; NITRIC OXIDE; PROGRAMMED DEATH 1 RECEPTOR; PROSTAGLANDIN E2; SEMAPHORIN 3A; THY 1 ANTIGEN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN PRESENTING CELL; ANTIPROLIFERATIVE ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL CONTACT; CELL DIFFERENTIATION; CELL MIGRATION; CELL RENEWAL; CELL SURVIVAL; CELLULAR IMMUNITY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STROMA CELL; MICROENVIRONMENT; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL; ADIPOCYTE; CARTILAGE CELL; CYTOLOGY; GENETICS; IMMUNOLOGY; OSTEOBLAST;

ADIPOCYTES; CELL DIFFERENTIATION; CHONDROCYTES; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSION; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; T-LYMPHOCYTES;

EID: 84904129414     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/216806     Document Type: Review

References (190)

1. Friedenstein A. J., Petrakova K. V., Kurolesova A. I., Frolova G. P., Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968 6 2 230 247 2-s2.0-0014261390
2. Friedenstein A. J., Chailakhjan R. K., Lalykina K. S., The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetics 1970 3 4 393 403 2-s2.0-0014855869
3. Caplan A. I., Mesenchymal stem cells. Journal of Orthopaedic Research 1991 9 5 641 650 2-s2.0-0026228558
4. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F. C., Krause D. S., Deans R. J., Keating A., Prockop D. J., Horwitz E. M., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006 8 4 315 317 2-s2.0-33747713246 10.1080/14653240600855905 (Pubitemid 44269669)
5. Parker G. C., Anastassova-Kristeva M., Eisenberg L. M., Rao M. S., Williams M. A., Sanberg P. R., English D., Stem cells: shibboleths of development, part II: toward a functional definition. Stem Cells and Development 2005 14 5 463 469 2-s2.0-28844466917 10.1089/scd.2005.14.463 (Pubitemid 41780798)
6. Friedenstein A. J., Chailakhyan R. K., Latsinik N. V., Panasyuk A. F., Keiliss-Borok I. V., Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974 17 4 331 340 2-s2.0-0016269155 10.1097/00007890-197404000-00001
7. Covas D. T., Panepucci R. A., Fontes A. M., Silva W. A. Jr., Orellana M. D., Freitas M. C. C., Neder L., Santos A. R. D., Peres L. C., Jamur M. C., Zago M. A., Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Experimental Hematology 2008 36 5 642 654 2-s2.0-42249092647 10.1016/j.exphem.2007.12.015
8. da Silva Meirelles L., Caplan A. I., Nardi N. B., In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008 26 9 2287 2299 2-s2.0-55049092713 10.1634/stemcells.2007-1122
9. Caplan A. I., Bruder S. P., Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends in Molecular Medicine 2001 7 6 259 264 2-s2.0-0034975453 10.1016/S1471-4914(01)02016-0 (Pubitemid 32545522)
10. Devine S. M., Cobbs C., Jennings M., Bartholomew A., Hoffman R., Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003 101 8 2999 3001 2-s2.0-0038281370 10.1182/blood-2002-06-1830 (Pubitemid 36857986)
11. da Silva Meirelles L., Fontes A. M., Covas D. T., Caplan A. I., Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine and Growth Factor Reviews 2009 20 5-6 419 427 2-s2.0-70849103924 10.1016/j.cytogfr.2009.10.002
12. Fiorina P., Voltarelli J., Zavazava N., Immunological applications of stem cells in type 1 diabetes. Endocrine Reviews 2011 32 6 725 754 2-s2.0-83755195365 10.1210/er.2011-0008
13. Tse W. T., Pendleton J. D., Beyer W. M., Egalka M. C., Guinan E. C., Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003 75 3 389 397 2-s2.0-0037442264 10.1097/01.TP.0000045055.63901.A9 (Pubitemid 36222968)
14. Klyushnenkova E., Mosca J. D., Zernetkina V., Majumdar M. K., Beggs K. J., Simonetti D. W., Deans R. J., McIntosh K. R., T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. Journal of Biomedical Science 2005 12 1 47 57 2-s2.0-17744365164 10.1007/s11373-004-8183-7 (Pubitemid 40576763)
15. Rasmusson I., Ringdén O., Sundberg B., Le Blanc K., Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003 76 8 1208 1213 2-s2.0-0242300602 10.1097/01.TP.0000082540.43730.80 (Pubitemid 37339646)
16. Najar M., Raicevic G., Fayyad-Kazan H., de Bruyn C., Bron D., Toungouz M., Lagneaux L., Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming. Stem Cell Reviews and Reports 2012 8 4 1188 1198 2-s2.0-84870313562 10.1007/s12015-012-9408-1
17. Briones J., Novelli S., Sierra J., T-cell costimulatory molecules in acute-graft-versus host disease: therapeutic implications. Bone Marrow Research 2011 2011 7 976793 10.1155/2011/976793
18. Nicola M. D., Carlo-Stella C., Magni M., Milanesi M., Longoni P. D., Matteucci P., Grisanti S., Gianni A. M., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002 99 10 3838 3843 2-s2.0-0037093058 10.1182/blood.V99.10.3838 (Pubitemid 34534559)
19. Le Blanc K., Tammik L., Sundberg B., Haynesworth S. E., Ringdén O., Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scandinavian Journal of Immunology 2003 57 1 11 20 2-s2.0-0042740515 10.1046/j.1365-3083.2003.01176.x (Pubitemid 38019084)
20. Krampera M., Cosmi L., Angeli R., Pasini A., Liotta F., Andreini A., Santarlasci V., Mazzinghi B., Pizzolo G., Vinante F., Romagnani P., Maggi E., Romagnani S., Annunziato F., Role for interferon- γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006 24 2 386 398 2-s2.0-33746889097 10.1634/stemcells.2005-0008 (Pubitemid 44464808)
21. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., Uccelli A., Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005 106 5 1755 1761 2-s2.0-23944519424 10.1182/blood-2005-04-1496 (Pubitemid 41208591)
22. Glennie S., Soeiro I., Dyson P. J., Lam E. W.-F., Dazzi F., Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005 105 7 2821 2827 2-s2.0-15944376184 10.1182/blood-2004-09-3696 (Pubitemid 40446275)
23. Uccelli A., Moretta L., Pistoia V., Immunoregulatory function of mesenchymal stem cells. European Journal of Immunology 2006 36 10 2566 2573 2-s2.0-33750233770 10.1002/eji.200636416 (Pubitemid 44608440)
24. Xu G., Zhang Y., Zhang L., Ren G., Shi Y., The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells. Biochemical and Biophysical Research Communications 2007 361 3 745 750 2-s2.0-34547791338 10.1016/j.bbrc.2007.07.052 (Pubitemid 47238033)
25. Benvenuto F., Ferrari S., Gerdoni E., Gualandi F., Frassoni F., Pistoia V., Mancardi G., Uccelli A., Human mesenchymal stem cells promote survival of T cells in a quiescent state. Stem Cells 2007 25 7 1753 1760 2-s2.0-34547212527 10.1634/stemcells.2007-0068 (Pubitemid 47121854)
26. Groh M. E., Maitra B., Szekely E., Koç O. N., Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Experimental Hematology 2005 33 8 928 934 2-s2.0-22144473736 10.1016/j.exphem.2005.05.002 (Pubitemid 40982660)
27. Le Blanc K., Rasmusson I., Götherström C., Seidel C., Sundberg B., Sundin M., Rosendahl K., Tammik C., Ringdén O., Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scandinavian Journal of Immunology 2004 60 3 307 315 2-s2.0-4344683220 10.1111/j.0300-9475.2004.01483.x (Pubitemid 39141263)
28. Ramasamy R., Tong C. K., Seow H. F., Vidyadaran S., Dazzi F., The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cellular Immunology 2008 251 2 131 136 2-s2.0-47249117877 10.1016/j.cellimm.2008.04.009
29. Majumdar M. K., Keane-Moore M., Buyaner D., Hardy W. B., Moorman M. A., McIntosh K. R., Mosca J. D., Characterization and functionality of cell surface molecules on human mesenchymal stem cells. Journal of Biomedical Science 2003 10 2 228 241 2-s2.0-0037221583 10.1159/000068710 (Pubitemid 36302404)
30. Suva D., Passweg J., Arnaudeau S., Hoffmeyer P., Kindler V., In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them. Journal of Cellular Physiology 2008 214 3 588 594 2-s2.0-38449114611 10.1002/jcp.21244 (Pubitemid 351224202)
31. Quaedackers M. E., Baan C. C., Weimar W., Hoogduijn M. J., Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes. European Journal of Immunology 2009 39 12 3436 3446 2-s2.0-73249121388 10.1002/eji.200939584
32. Ren G., Zhang L., Zhao X., Xu G., Zhang Y., Roberts A. I., Zhao R. C., Shi Y., Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008 2 2 141 150 2-s2.0-38649105374 10.1016/j.stem.2007.11.014 (Pubitemid 351181031)
33. Ren G., Zhao X., Zhang L., Zhang J., L'Huillier A., Ling W., Roberts A. I., Le A. D., Shi S., Shao C., Shi Y., Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. The Journal of Immunology 2010 184 5 2321 2328 2-s2.0-77951889580 10.4049/jimmunol.0902023
34. Najar M., Raicevic G., Id Boufker H., Stamatopoulos B., De Bruyn C., Meuleman N., Bron D., Toungouz M., Lagneaux L., Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. Experimental Hematology 2010 38 10 922 932 2-s2.0-77956617456 10.1016/j.exphem.2010.05.007
35. Chinnadurai R., Copland I. B., Patel S. R., Galipeau J., IDO-independent suppression of T cell effector function by IFN- γ -licensed human mesenchymal stromal cells. The Journal of Immunology 2014 192 4 1491 1501 10.4049/jimmunol.1301828
36. Augello A., Tasso R., Negrini S. M., Amateis A., Indiveri F., Cancedda R., Pennesi G., Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. European Journal of Immunology 2005 35 5 1482 1490 2-s2.0-18844404360 10.1002/eji.200425405 (Pubitemid 40691430)
37. Djouad F., Plence P., Bony C., Tropel P., Apparailly F., Sany J., Noël D., Jorgensen C., Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003 102 10 3837 3844 2-s2.0-0242410394 10.1182/blood-2003-04-1193 (Pubitemid 37409409)
38. Anzalone R., Iacono M. L., Loria T., Stefano A. D., Giannuzzi P., Farina F., la Rocca G., Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes. Stem Cell Reviews and Reports 2011 7 2 342 363 2-s2.0-79954994410 10.1007/s12015-010-9196- 4
39. Meisel R., Zibert A., Laryea M., Göbel U., Däubener W., Dilloo D., Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004 103 12 4619 4621 2-s2.0-2942595706 10.1182/blood-2003-11-3909 (Pubitemid 38745993)
40. Aggarwal S., Pittenger M. F., Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005 105 4 1815 1822 2-s2.0-13544249606 10.1182/blood-2004-04-1559 (Pubitemid 40223708)
41. Sato K., Ozaki K., Oh I., Meguro A., Hatanaka K., Nagai T., Muroi K., Ozawa K., Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007 109 1 228 234 2-s2.0-33846006154 10.1182/blood-2006-02-002246 (Pubitemid 46053063)
42. Najar M., Rouas R., Raicevic G., Boufker H. I., Lewalle P., Meuleman N., Bron D., Toungouz M., Martiat P., Lagneaux L., Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy 2009 11 5 570 583 2-s2.0-70849116391 10.1080/14653240903079377
43. Yang S.-H., Park M.-J., Yoon I.-H., Kim S.-Y., Hong S.-H., Shin J.-Y., Nam H.-Y., Kim Y.-H., Kim B., Park C.-G., Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Experimental and Molecular Medicine 2009 41 5 315 324 2-s2.0-66749176001 10.3858/emm.2009.41.5. 035
44. Lepelletier Y., Lecourt S., Renand A., Arnulf B., Vanneaux V., Fermand J.-P., Menasché P., Domet T., Marolleau J.-P., Hermine O., Larghero J., Galectin-1 and semaphorin-3A are two soluble factors conferring t-cell immunosuppression to bone marrow mesenchymal stem cell. Stem Cells and Development 2010 19 7 1075 1079 2-s2.0-77954932147 10.1089/scd.2009.0212
45. Gieseke F., Böhringer J., Bussolari R., Dominici M., Handgretinger R., Müller I., Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 2010 116 19 3770 3779 2-s2.0-78149439868 10.1182/blood-2010-02-270777
46. Gieseke F., Kruchen A., Tzaribachev N., Bentzien F., Dominici M., Müller I., Proinflammatory stimuli induce galectin- in human mesenchymal stromal cells to suppress T-cell proliferation. European Journal of Immunology 2013 43 10 2741 2799
47. Meisel R., Brockers S., Heseler K., Degistirici O., Bülle H., Woite C., Stuhlsatz S., Schwippert W., Jäger M., Sorg R., Henschler R., Seissler J., Dilloo D., Däubener W., Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 2011 25 4 648 654 2-s2.0-79958295717
48. Su J., Chen X., Huang Y., Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species. Cell Death & Differentiation 2014 21 3 388 396
49. Ren G., Su J., Zhang L., Zhao X., Ling W., L'Huillie A., Zhang J., Lu Y., Roberts A. I., Ji W., Zhang H., Rabson A. B., Shi Y., Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 2009 27 8 1954 1962 2-s2.0-69249119079 10.1002/stem.118
50. Saldanha-Araujo F., Ferreira F. I. S., Palma P. V., Araujo A. G., Queiroz R. H. C., Covas D. T., Zago M. A., Panepucci R. A., Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes. Stem Cell Research 2011 7 1 66 74 2-s2.0-79956361542 10.1016/j.scr.2011.04.001
51. Sattler C., Steinsdoerfer M., Offers M., Fischer E., Schierl R., Heseler K., Däubener W., Seissler J., Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation. Cell Transplantation 2011 20 8 1221 1230 2-s2.0-80755187571 http://dx.doi.org/10.3727/096368910X546553
52. Bassi Ê. J., de Almeida D. C., Moraes-Vieira P. M. M., Câmara N. O. S., Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells. Stem Cell Reviews and Reports 2012 8 2 329 342 2-s2.0-84861669648 10.1007/s12015-011-9311-1
53. Rasmusson I., Ringdén O., Sundberg B., Le Blanc K., Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Experimental Cell Research 2005 305 1 33 41 2-s2.0-15044348816 10.1016/j.yexcr.2004.12.013 (Pubitemid 40380651)
54. Sakaguchi S., Yamaguchi T., Nomura T., Ono M., Regulatory T cells and immune tolerance. Cell 2008 133 5 775 787 2-s2.0-43949105866 10.1016/j.cell.2008.05.009 (Pubitemid 351707693)
55. Wood K. J., Bushell A., Hester J., Regulatory immune cells in transplantation. Nature Reviews Immunology 2012 12 6 417 430 2-s2.0-84861568296 10.1038/nri3227
56. Maccario R., Podestà M., Moretta A., Cometa A., Comoli P., Montagna D., Daudt L., Ibatici A., Piaggio G., Pozzi S., Frassoni F., Locatelli F., Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4 + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005 90 4 516 525 2-s2.0-17844391825 (Pubitemid 40592895)
57. di Ianni M., del Papa B., de Ioanni M., Moretti L., Bonifacio E., Cecchini D., Sportoletti P., Falzetti F., Tabilio A., Mesenchymal cells recruit and regulate T regulatory cells. Experimental Hematology 2008 36 3 309 318 2-s2.0-38949175025 10.1016/j.exphem.2007.11.007 (Pubitemid 351221170)
58. Selmani Z., Naji A., Zidi I., Favier B., Gaiffe E., Obert L., Borg C., Saas P., Tiberghien P., Rouas-Freiss N., Carosella E. D., Deschaseaux F., Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+ CD25highFOXP3+ regulatory T cells. Stem Cells 2008 26 1 212 222 2-s2.0-38349053355 10.1634/stemcells.2007-0554
59. Trzonkowski P., Bieniaszewska M., Juścińska J., Dobyszuk A., Krzystyniak A., Marek N., Myśliwska J., Hellmann A., First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clinical Immunology 2009 133 1 22 26 2-s2.0-70249122695 10.1016/j.clim.2009.06.001
60. Riley J. L., June C. H., Blazar B. R., Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 2009 30 5 656 665 2-s2.0-65549127618 10.1016/j.immuni.2009.04.006
61. Bilate A. M., Lafaille J. J., Induced CD4 +Foxp3 + regulatory T cells in immune tolerance. Annual Review of Immunology 2012 30 733 758 2-s2.0-84859390119 10.1146/annurev-immunol-020711-075043
62. Bailey-Bucktrout S. L., Bluestone J. A., Regulatory T cells: stability revisited. Trends in Immunology 2011 32 7 301 306 2-s2.0-80955178941 10.1016/j.it.2011.04.002
63. English K., Ryan J. M., Tobin L., Murphy M. J., Barry F. P., Mahon B. P., Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells. Clinical and Experimental Immunology 2009 156 1 149 160 2-s2.0-61849123247 10.1111/j.1365-2249.2009.03874. x
64. Nasef A., Mazurier C., Bouchet S., François S., Chapel A., Thierry D., Gorin N.-C., Fouillard L., Leukemia inhibitory factor: role in human mesenchymal stem cells mediated immunosuppression. Cellular Immunology 2008 253 1-2 16 22 2-s2.0-51649108020 10.1016/j.cellimm.2008.06.002
65. Najar M., Raicevic G., Boufker H. I., Fayyad-Kazan H., De Bruyn C., Meuleman N., Bron D., Toungouz M., Lagneaux L., Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Engineering A 2010 16 11 3537 3546 2-s2.0-78149265779 10.1089/ten.tea.2010.0159
66. del Papa B., Sportoletti P., Cecchini D., Rosati E., Balucani C., Baldoni S., Fettucciari K., Marconi P., Martelli M. F., Falzetti F., Di Ianni M., Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction. European Journal of Immunology 2013 43 1 182 187 2-s2.0-84872498240 10.1002/eji.201242643
67. Li J., Zhuan-sun Y., Wen B., Human mesenchymal stem cells elevate CD4+CD25+CD127low/- regulatory T cells of asthmatic patients via heme oxygenase-1. Iranian Journal of Allergy, Asthma and Immunology 2013 12 3 228 235
68. Mougiakakos D., Jitschin R., Johansson C. C., Okita R., Kiessling R., Le Blanc K., The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 2011 117 18 4826 4835 2-s2.0-79955971620 10.1182/blood-2010-12-324038
69. Melief S. M., Schrama E., Brugman M. H., Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells 2013 31 9 1980 1991 10.1002/stem.1432
70. Prevosto C., Zancolli M., Canevali P., Zocchi M. R., Poggi A., Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 2007 92 7 881 888 2-s2.0-34548739534 10.3324/haematol.11240 (Pubitemid 350144234)
71. Saldanha-Araujo F., Haddad R., Malmegrim de Farias K. C. R., de Paula Alves Souza A., Palma P. V., Araujo A. G., Orellana M. D., Voltarelli J. C., Covas D. T., Zago M. A., Panepucci R. A., Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF- B signalling. Journal of Cellular and Molecular Medicine 2012 16 6 1232 1244 2-s2.0-84861546167 10.1111/j.1582-4934.2011.01391.x
72. Sancho D., Gómez M., Sánchez-Madrid F., CD69 is an immunoregulatory molecule induced following activation. Trends in Immunology 2005 26 3 136 140 2-s2.0-14644387445 10.1016/j.it.2004.12.006 (Pubitemid 40312520)
73. Sancho D., Gómez M., Viedma F., Esplugues E., Gordón-Alonso M., García-López M. A., de la Fuente H., Martínez-A C., Lauzurica P., Sánchez-Madrid F., CD69 downregulates autoimmune reactivity through active transforming growth factor- β production in collagen-induced arthritis. Journal of Clinical Investigation 2003 112 6 872 882 2-s2.0-0142217899 10.1172/JCI200319112 (Pubitemid 38063745)
74. Yan Z., Zhuansun Y., Chen R., Li J., Ran P., Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism. Experimental Cell Research 2014 324 1 65 74 10.1016/j.yexcr.2014.03.013
75. Baratelli F., Lin Y., Zhu L., Yang S.-C., Heuzé-Vourc'h N., Zeng G., Reckamp K., Dohadwala M., Sharma S., Dubinett S. M., Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. The Journal of Immunology 2005 175 3 1483 1490 2-s2.0-22544436066 (Pubitemid 41023048)
76. Ghannam S., Pène J., Torcy-Moquet G., Jorgensen C., Yssel H., Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. The Journal of Immunology 2010 185 1 302 312 2-s2.0-77956215701 10.4049/jimmunol.0902007
77. Lee J. J., Jeong H. J., Kim M. K., CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell function. Purinergic Signalling 2014 10 2 357 365
78. Borsellino G., Kleinewietfeld M., di Mitri D., Sternjak A., Diamantini A., Giometto R., Höpner S., Centonze D., Bernardi G., Dell'Acqua M. L., Rossini P. M., Battistini L., Rötzschke O., Falk K., Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007 110 4 1225 1232 2-s2.0-34547098277 10.1182/blood-2006-12-064527 (Pubitemid 47281420)
79. Mandapathil M., Lang S., Gorelik E., Whiteside T. L., Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. Journal of Immunological Methods 2009 346 1-2 55 63 2-s2.0-67449128008 10.1016/j.jim.2009.05.004
80. Casiraghi F., Azzollini N., Cassis P., Imberti B., Morigi M., Cugini D., Cavinato R. A., Todeschini M., Solini S., Sonzogni A., Perico N., Remuzzi G., Noris M., Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. The Journal of Immunology 2008 181 6 3933 3946 2-s2.0-56149110595
81. Parekkadan B., Tilles A. W., Yarmush M. L., Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 2008 26 7 1913 1919 2-s2.0-55049135256 10.1634/stemcells.2007-0790
82. Gronthos S., Mankani M., Brahim J., Robey P. G., Shi S., Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 2000 97 25 13625 13630 2-s2.0-0034610376 10.1073/pnas.240309797
83. Gronthos S., Franklin D. M., Leddy H. A., Robey P. G., Storms R. W., Gimble J. M., Surface protein characterization of human adipose tissue-derived stromal cells. Journal of Cellular Physiology 2001 189 1 54 63
84. Toma J. G., Akhavan M., Fernandes K. J. L., Barnabé-Heider F., Sadikot A., Kaplan D. R., Miller F. D., Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nature Cell Biology 2001 3 9 778 784 2-s2.0-0034848122 10.1038/ncb0901-778 (Pubitemid 32842682)
85. Erices A., Conget P., Minguell J. J., Mesenchymal progenitor cells in human umbilical cord blood. British Journal of Haematology 2000 109 1 235 242 2-s2.0-0034079140 10.1046/j.1365-2141.2000.01986.x (Pubitemid 30340601)
86. Campagnoli C., Roberts I. A. G., Kumar S., Bennett P. R., Bellantuono I., Fisk N. M., Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001 98 8 2396 2402 2-s2.0-0035889146 10.1182/blood.V98.8.2396
87. de Bari C., Dell'Accio F., Tylzanowski P., Luyten F. P., Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis & Rheumatology 2001 44 8 1928 1942 (Pubitemid 32758241)
88. Hu Y., Liao L., Wang Q., Ma L., Ma G., Jiang X., Zhao R. C., Isolation and identification of mesenchymal stem cells from human fetal pancreas. Journal of Laboratory and Clinical Medicine 2003 141 5 342 349 2-s2.0-0037951745 10.1016/S0022-2143(03)00022-2 (Pubitemid 36578102)
89. In 't Anker P. S., Noort W. A., Kruisselbrink A. B., Scherjon S. A., Beekhuizen W., Willemze R., Kanhai H. H. H., Fibbe W. E., Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34+ cells in NOD/SCID mice. Experimental Hematology 2003 31 10 881 889 2-s2.0-0141484486 10.1016/S0301-472X(03)00202-9 (Pubitemid 37211372)
90. In't Anker P. S., Scherjon S. A., Kleijburg-van der Keur C., de Groot-Swings G. M. J. S., Claas F. H. J., Fibbe W. E., Kanhai H. H. H., Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004 22 7 1338 1345 2-s2.0-10444275247 10.1634/stemcells. 2004-0058 (Pubitemid 39636409)
91. In 't Anker P. S., Scherjon S. A., Kleijburg-van der Keur C., Noort W. A., Claas F. H. J., Willemze R., Fibbe W. E., Kanhai H. H. H., Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003 102 4 1548 1549 2-s2.0-0042237666 10.1182/blood-2003-04-1291 (Pubitemid 36988070)
92. Roufosse C. A., Direkze N. C., Otto W. R., Wright N. A., Circulating mesenchymal stem cells. International Journal of Biochemistry and Cell Biology 2004 36 4 585 597 2-s2.0-1542269027 10.1016/j.biocel.2003.10.007 (Pubitemid 38316816)
93. Friedenstein A. J., Gorskaja U. F., Kulagina N. N., Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Experimental Hematology 1976 4 5 267 274 2-s2.0-0017119380
94. Anzalone R., Iacono M. L., Corrao S., Magno F., Loria T., Cappello F., Zummo G., Farina F., La Rocca G., New emerging potentials for human wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells and Development 2010 19 4 423 438 2-s2.0-77950603767 10.1089/scd.2009.0299
95. Kern S., Eichler H., Stoeve J., Klüter H., Bieback K., Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006 24 5 1294 1301 2-s2.0-33745437684 10.1634/stemcells.2005-0342 (Pubitemid 44464698)
96. Najar M., Raicevic G., Boufker H. I., Kazan H. F., Bruyn C. D., Meuleman N., Bron D., Toungouz M., Lagneaux L., Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. Cellular Immunology 2010 264 2 171 179 2-s2.0-77955093536 10.1016/j.cellimm.2010.06.006
97. Zhou C., Yang B., Tian Y., Jiao H., Zheng W., Wang J., Guan F., Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. Cellular Immunology 2011 272 1 33 38 2-s2.0-80455160153 10.1016/j.cellimm.2011.09.010
98. Shi D., Liao L., Zhang B., Liu R., Dou X., Li J., Zhu X., Yu L., Chen D., Zhao R. C. H., Human adipose tissue-derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF- B signaling. Experimental Hematology 2011 39 2 214.e1 224.e1 2-s2.0-78751482487 10.1016/j.exphem.2010.10.009
99. Yoo K. H., Jang I. K., Lee M. W., Kim H. E., Yang M. S., Eom Y., Lee J. E., Kim Y. J., Yang S. K., Jung H. L., Sung K. W., Kim C. W., Koo H. H., Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cellular Immunology 2009 259 2 150 156 2-s2.0-70349121293 10.1016/j.cellimm.2009.06.010
100. Li C., Zhang W., Jiang X., Mao N., Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells. Cell and Tissue Research 2007 330 3 437 446 2-s2.0-36049011643 10.1007/s00441-007- 0504-5 (Pubitemid 350098216)
101. Chang C.-J., Yen M.-L., Chen Y.-C., Chien C.-C., Huang H.-I., Bai C.-H., Yen B. L., Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon- γ Stem Cells 2006 24 11 2466 2477 2-s2.0-33750563599 10.1634/stemcells.2006-0071 (Pubitemid 44674307)
102. Yañez R., Lamana M. L., García-Castro J., Colmenero I., Ramírez M., Bueren J. A., Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006 24 11 2582 2591 2-s2.0-33750559121 10.1634/stemcells.2006-0228 (Pubitemid 44674320)
103. Jarvinen L., Badri L., Wettlaufer S., Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. The Journal of Immunology 2008 181 6 4389 4396
104. Jones B. J., Brooke G., Atkinson K., McTaggart S. J., Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells. Placenta 2007 28 11-12 1174 1181 2-s2.0-35348823105 10.1016/j.placenta.2007.07. 001 (Pubitemid 47570911)
105. Tipnis S., Viswanathan C., Majumdar A. S., Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO. Immunology and Cell Biology 2010 88 8 795 806 2-s2.0-78649333063 10.1038/icb.2010.47
106. Weiss M. L., Anderson C., Medicetty S., Seshareddy K. B., Weiss R. J., VanderWerff I., Troyer D., McIntosh K. R., Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008 26 11 2865 2874 2-s2.0-56249139741 10.1634/stemcells.2007-1028
107. Cutler A. J., Limbani V., Girdlestone J., Navarrete C. V., Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. The Journal of Immunology 2010 185 11 6617 6623 2-s2.0-78650673843 10.4049/jimmunol.1002239
108. Jurgens W. J. F. M., Oedayrajsingh-Varma M. J., Helder M. N., ZandiehDoulabi B., Schouten T. E., Kuik D. J., Ritt M. J. P. F., Van Milligen F. J., Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell and Tissue Research 2008 332 3 415 426 2-s2.0-43549093524 10.1007/s00441-007-0555-7 (Pubitemid 351677811)
109. Hass R., Kasper C., Böhm S., Jacobs R., Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Communication and Signaling 2011 9, article 12 2-s2.0-79955795428 10.1186/1478-811X-9-12
110. Vasandan A. B., Shankar S. R., Prasad P., Sowmya Jahnavi V., Bhonde R. R., Jyothi Prasanna S., Functional differences in mesenchymal stromal cells from human dental pulp and periodontal ligament. Journal of Cellular and Molecular Medicine 2014 18 2 344 354
111. Castro-Manrreza M., Mayani H., Monroy-Garcia A., Human mesenchymal stromal cells from adult and neonatal sources: a comparative in vitro analysis of their immunosuppressive properties against T cells. Stem Cells and Development 2014 123 11 1217 1232 10.1089/scd.2013.0363
112. Parolini O., Alviano F., Bagnara G. P., Bilic G., Bühring H.-J., Evangelista M., Hennerbichler S., Liu B., Magatti M., Mao N., Miki T., Marongiu F., Nakajima H., Nikaido T., Portmann-Lanz C. B., Sankar V., Soncini M., Stadler G., Surbek D., Takahashi T. A., Redl H., Sakuragawa N., Wolbank S., Zeisberger S., Zisch A., Strom S. C., Concise review: isolation and characterization of cells from human term placenta: outcome of the First International Workshop on Placenta Derived Stem Cells. Stem Cells 2008 26 2 300 311 2-s2.0-40949143606 10.1634/stemcells.2007-0594 (Pubitemid 351413589)
113. di Trapani M., Bassi G., Ricciardi M., Comparative study of immune regulatory properties of stem cells derived from different tissues. Stem Cells and Development 2013 22 22 2990 3002
114. Battula V. L., Treml S., Bareiss P. M., Gieseke F., Roelofs H., de Zwart P., Müller I., Schewe B., Skutella T., Fibbe W. E., Kanz L., Bühring H.-J., Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 2009 94 2 173 184 2-s2.0-59449093151 10.3324/haematol.13740
115. Bühring H.-J., Treml S., Cerabona F., de Zwart P., Kanz L., Sobiesiak M., Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Annals of the New York Academy of Sciences 2009 1176 124 134 2-s2.0-70349808974 10.1111/j.1749-6632.2009.04564.x
116. Arufe M. C., de la Fuente A., Fuentes I., de Toro F. J., Blanco F. J., Chondrogenic potential of subpopulations of cells expressing mesenchymal stem cell markers derived from human synovial membranes. Journal of Cellular Biochemistry 2010 111 4 834 845 2-s2.0-78049317724 10.1002/jcb.22768
117. de Francesco F., Tirino V., Desiderio V., Ferraro G., D'Andrea F., Giuliano M., Libondi G., Pirozzi G., De Rosa A., Papaccio G., Human CD34+/CD90+ ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries. PLoS ONE 2009 4 8 2-s2.0-68449104766 10.1371/journal.pone.0006537 e6537
118. Traktuev D. O., Merfeld-Clauss S., Li J., Kolonin M., Arap W., Pasqualini R., Johnstone B. H., March K. L., A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circulation Research 2008 102 1 77 85 2-s2.0-37849026091 10.1161/CIRCRESAHA.107.159475
119. Baer P. C., Kuçi S., Krause M., Kuçi Z., Zielen S., Geiger H., Bader P., Schubert R., Comprehensive phenotypic characterization of human adipose-derived stromal/stem cells and their subsets by a high throughput technology. Stem Cells and Development 2013 22 2 330 339 2-s2.0-84872450710 10.1089/scd.2012.0346
120. Simmons P. J., Torok-Storb B., CD34 expression by stromal precursors in normal human adult bone marrow. Blood 1991 78 11 2848 2853 2-s2.0-0025720031
121. Lin C.-S., Ning H., Lin G., Lue T. F., Is CD34 truly a negative marker for mesenchymal stromal cells? Cytotherapy 2012 14 10 1159 1163 2-s2.0-84867657863 10.3109/14653249.2012.729817
122. Mitchell J. B., McIntosh K., Zvonic S., Garrett S., Floyd Z. E., Kloster A., Di Halvorsen Y., Storms R. W., Goh B., Kilroy G., Wu X., Gimble J. M., Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006 24 2 376 385 2-s2.0-33746868358 10.1634/stemcells.2005-0234 (Pubitemid 44464807)
123. Simmons P. J., Torok-Storb B., Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991 78 1 55 62 2-s2.0-0025741349
124. Nasef A., Zhang Y. Z., Mazurier C., Bouchet S., Bensidhoum M., Francois S., Gorin N. C., Lopez M., Thierry D., Fouillard L., Chapel A., Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. International Journal of Laboratory Hematology 2009 31 1 9 19 2-s2.0-58449131093 10.1111/j.1751-553X.2007.00997.x
125. Campioni D., Rizzo R., Stignani M., Melchiorri L., Ferrari L., Moretti S., Russo A., Bagnara G. P., Bonsi L., Alviano F., Lanzoni G., Cuneo A., Baricordi O. R., Lanza F., A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs. Cytometry B: Clinical Cytometry 2009 76 3 225 230 2-s2.0-66949138068 10.1002/cyto.b.20461
126. Kuçi Z., Kuçi S., Zircher S., Koller S., Schubert R., Bönig H., Henschler R., Lieberz R., Klingebiel T., Bader P., Mesenchymal stromal cells derived from CD271+ bone marrow mononuclear cells exert potent allosuppressive properties. Cytotherapy 2011 13 10 1193 1204 2-s2.0-80054751619 10.3109/14653249.2011.605118
127. Yang Z. X., Han Z.-B., Ji Y. R., Wang Y. W., Liang L., Chi Y., Yang S. G., Li L. N., Luo W. F., Li J. P., Da Chen D., Du W. J., Cao X. C., Zhuo G. S., Wang T., Han Z. C., CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS ONE 2013 8 3 2-s2.0-84874919298 10.1371/journal.pone.0059354 e59354
128. Krampera M., Mesenchymal stromal cell licensing: a multistep process. Leukemia 2011 25 9 1408 1414 2-s2.0-80052487336 10.1038/leu.2011.108
129. Dazzi F., Ramasamy R., Glennie S., Jones S. P., Roberts I., The role of mesenchymal stem cells in haemopoiesis. Blood Reviews 2006 20 3 161 171 2-s2.0-33646015065 10.1016/j.blre.2005.11.002
130. Kurosaka D., Lebien T. W., Pribyl J. A. R., Comparative studies of different stromal cell microenvironments in support of human B-cell development. Experimental Hematology 1999 27 8 1271 1281 2-s2.0-0032800455 10.1016/S0301-472X(99)00067-3 (Pubitemid 29347476)
131. Traggiai E., Volpi S., Schena F., Gattorno M., Ferlito F., Moretta L., Martini A., Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 2008 26 2 562 569 2-s2.0-40949119840 10.1634/stemcells.2007-0528 (Pubitemid 351413617)
132. Tabera S., Pérez-Simón J. A., Díez-Campelo M., The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 2008 93 9 1301 1309
133. François M., Romieu-Mourez R., Stock-Martineau S., Boivin M.-N., Bramson J. L., Galipeau J., Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties. Blood 2009 114 13 2632 2638 2-s2.0-70350512378 10.1182/blood-2009-02-207795
134. Sánchez-Abarca L. I., Alvarez-Laderas I., Díez Campelo M., Uptake and delivery of antigens by mesenchymal stromal cells. Cytotherapy 2013 15 6 673 678
135. Bian Z.-Y., Fan Q.-M., Li G., Xu W.-T., Tang T.-T., Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2. Cancer Science 2010 101 12 2554 2560 2-s2.0-78449297256 10.1111/j.1349-7006.2010.01731.x
136. de Boeck A., Pauwels P., Hensen K., Rummens J.-L., Westbroek W., Hendrix A., Maynard D., Denys H., Lambein K., Braems G., Gespach C., Bracke M., De Wever O., Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut 2013 62 4 550 560 2-s2.0-84874666281 10.1136/gutjnl-2011-301393
137. Liu Y., Han Z.-P., Zhang S.-S., Jing Y.-Y., Bu X.-X., Wang C.-Y., Sun K., Jiang G.-C., Zhao X., Li R., Gao L., Zhao Q.-D., Wu M.-C., Wei L.-X., Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. The Journal of Biological Chemistry 2011 286 28 25007 25015 2-s2.0-79960130552 10.1074/jbc.M110.213108
138. Suzuki K., Sun R., Origuch M., Kanehira M., Takahata T., Itoh J., Umezawa A., Kijima H., Fukuda S., Saijo Y., Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Molecular Medicine 2011 17 7-8 579 587 2-s2.0-79960720038 10.2119/molmed.2010.00157
139. Zhang T., Lee Y. W., Rui Y. F., Cheng T. Y., Jiang X. H., Li G., Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Research and Therapy 2013 4 3, article 70 2-s2.0-84878818425 10.1186/scrt221
140. Mandel K., Yang Y., Schambach A., Glage S., Otte A., Hass R., Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo. Stem Cells and Development 2013 22 23 3114 3127
141. Rappa G., Mercapide J., Lorico A., Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. American Journal of Pathology 2012 180 6 2504 2515 2-s2.0-84861580867 10.1016/j.ajpath.2012.02.020
142. Cheng J., Ye H., Liu Z., Xu C., Zhang Z., Liu Y., Sun Y., Platelet-derived growth factor-BB accelerates prostate cancer growth by promoting the proliferation of mesenchymal stem cells. Journal of Cellular Biochemistry 2013 114 7 1510 1518 2-s2.0-84877695000 10.1002/jcb.24492
143. Karnoub A. E., Dash A. B., Vo A. P., Sullivan A., Brooks M. W., Bell G. W., Richardson A. L., Polyak K., Tubo R., Weinberg R. A., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007 449 7162 557 563 2-s2.0-34948896045 10.1038/nature06188 (Pubitemid 47525152)
144. Shinagawa K., Kitadai Y., Tanaka M., Sumida T., Kodama M., Higashi Y., Tanaka S., Yasui W., Chayama K., Mesenchymal stem cells enhance growth and metastasis of colon cancer. International Journal of Cancer 2010 127 10 2323 2333 2-s2.0-78049517433 10.1002/ijc.25440
145. Jung Y., Kim J. K., Shiozawa Y., Wang J., Mishra A., Joseph J., Berry J. E., McGee S., Lee E., Sun H., Wang J., Jin T., Zhang H., Dai J., Krebsbach P. H., Keller E. T., Pienta K. J., Taichman R. S., Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nature Communications 2013 4, article 1795 2-s2.0-84877724314 10.1038/ncomms2766
146. Hong I. S., Lee H. Y., Kang K. S., Mesenchymal stem cells and cancer: friends or enemies? Mutation Research 2014
147. Barcellos-de-Souza P., Gori V., Bambi F., Chiarugi P., Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochimica et Biophysica Acta 2013 1836 2 321 335
148. Qiao L., Xu Z., Zhao T., Zhao Z., Shi M., Zhao R. C., Ye L., Zhang X., Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Research 2008 18 4 500 507 2-s2.0-41849115243 10.1038/cr.2008.40 (Pubitemid 351498857)
149. Qiao L., Xu Z.-L., Zhao T.-J., Ye L.-H., Zhang X.-D., Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Letters 2008 269 1 67 77 2-s2.0-49349100584 10.1016/j.canlet.2008.04.032
150. Khakoo A. Y., Pati S., Anderson S. A., Reid W., Elshal M. F., Rovira I. I., Nguyen A. T., Malide D., Combs C. A., Hall G., Zhang J., Raffeld M., Rogers T. B., Stetler-Stevenson W., Frank J. A., Reitz M., Finkel T., Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. Journal of Experimental Medicine 2006 203 5 1235 1247 2-s2.0-33646690027 10.1084/jem.20051921
151. Moon R. T., Kohn A. D., de Ferrari G. V., Kaykas A., WNT and β -catenin signalling: diseases and therapies. Nature Reviews Genetics 2004 5 9 691 701 2-s2.0-4344584730 10.1038/nrg1427 (Pubitemid 39150127)
152. Vivanco I., Sawyers C. L., The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nature Reviews Cancer 2002 2 7 489 501 2-s2.0-0036632368 (Pubitemid 37328931)
153. Waterman R. S., Tomchuck S. L., Henkle S. L., Betancourt A. M., A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS ONE 2010 5 4 2-s2.0-77956420421 10.1371/journal.pone.0010088 e10088
154. English K., Mechanisms of mesenchymal stromal cell immunomodulation. Immunology and Cell Biology 2013 91 1 19 26 2-s2.0-84872144085 10.1038/icb.2012.56
155. English K., Barry F. P., Field-Corbett C. P., Mahon B. P., IFN- γ and TNF- α differentially regulate immunomodulation by murine mesenchymal stem cells. Immunology Letters 2007 110 2 91 100 2-s2.0-34249662219 10.1016/j.imlet.2007.04.001 (Pubitemid 46830943)
156. Rosenzweig S. D., Holland S. M., Defects in the interferon- γ and interleukin-12 pathways. Immunological Reviews 2005 203 38 47 2-s2.0-13144281722 10.1111/j.0105-2896.2005.00227.x (Pubitemid 40179692)
157. Foulds K. E., Wu C.-Y., Seder R. A., Th1 memory: implications for vaccine development. Immunological Reviews 2006 211 58 66 2-s2.0-33745110937 10.1111/j.0105-2896.2006.00400.x (Pubitemid 43882961)
158. Valencic E., Loganes C., Cesana S., Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media. Stem Cell Research & Therapy 2014 5 1 3
159. Polchert D., Sobinsky J., Douglas G. W., Kidd M., Moadsiri A., Reina E., Genrich K., Mehrotra S., Setty S., Smith B., Bartholomew A., IFN- γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. European Journal of Immunology 2008 38 6 1745 1755 2-s2.0-49649106257 10.1002/eji.200738129
160. Ryan J. M., Barry F., Murphy J. M., Mahon B. P., Interferon- γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clinical and Experimental Immunology 2007 149 2 353 363 2-s2.0-34447298069 10.1111/j.1365-2249.2007.03422.x (Pubitemid 47063057)
161. Delarosa O., Lombardo E., Beraza A., Mancheño-Corvo P., Ramirez C., Menta R., Rico L., Camarillo E., García L., Abad J. L., Trigueros C., Delgado M., Büscher D., Requirement of IFN- γ -mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Engineering A 2009 15 10 2795 2806 2-s2.0-73349122308 10.1089/ten.tea.2008.0630
162. Sheng H., Wang Y., Jin Y., Zhang Q., Zhang Y., Wang L., Shen B., Yin S., Liu W., Cui L., Li N., A critical role of IFN γ in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Research 2008 18 8 846 857 2-s2.0-49149120713 10.1038/cr.2008.80
163. Spaggiari G. M., Capobianco A., Becchetti S., Mingari M. C., Moretta L., Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006 107 4 1484 1490 2-s2.0-32644438233 10.1182/blood-2005-07-2775 (Pubitemid 43242385)
164. Chan J. L., Tang K. C., Patel A. P., Bonilla L. M., Pierobon N., Ponzio N. M., Rameshwar P., Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon- γ Blood 2006 107 12 4817 4824 2-s2.0-33745076513 10.1182/blood-2006-01-0057 (Pubitemid 43882633)
165. Stagg J., Pommey S., Eliopoulos N., Galipeau J., Interferon- γ -stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood 2006 107 6 2570 2577 2-s2.0-33644799418 10.1182/blood-2005-07-2793 (Pubitemid 43348704)
166. Zhang A., Wang Y., Ye Z., Xie H., Zhou L., Zheng S., Mechanism of TNF- α -induced migration and hepatocyte growth factor production in human mesenchymal stem cells. Journal of Cellular Biochemistry 2010 111 2 469 475 2-s2.0-77957255775 10.1002/jcb.22729
167. Miettinen J. A., Pietilä M., Salonen R. J., Ohlmeier S., Ylitalo K., Huikuri H. V., Lehenkari P., Tumor necrosis factor alpha promotes the expression of immunosuppressive proteins and enhances the cell growth in a human bone marrow-derived stem cell culture. Experimental Cell Research 2011 317 6 791 801 2-s2.0-79952195895 10.1016/j.yexcr.2010.12.010
168. Böcker W., Docheva D., Prall W. C., Egea V., Pappou E., Roßmann O., Popov C., Mutschler W., Ries C., Schieker M., IKK-2 is required for TNF- α -induced invasion and proliferation of human mesenchymal stem cells. Journal of Molecular Medicine 2008 86 10 1183 1192 2-s2.0-52549118412 10.1007/s00109-008-0378-3
169. Cuerquis J., Romieu-Mourez R., François M., Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon- γ and tumor necrosis factor- α stimulation. Cytotherapy 2014 16 2 191 202
170. Kemp K., Gray E., Mallam E., Scolding N., Wilkins A., Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells. Stem Cell Reviews and Reports 2010 6 4 548 559 2-s2.0-77957366312 10.1007/s12015-010-9178-6
171. Kwon M.-J., Jeon Y.-J., Lee K.-Y., Kim T.-Y., Superoxide dismutase 3 controls adaptive immune responses and contributes to the inhibition of ovalbumin-induced allergic airway inflammation in mice. Antioxidants and Redox Signaling 2012 17 10 1376 1392 2-s2.0-84866285250 10.1089/ars.2012.4572
172. Xu C., Ren G., Cao G., Chen Q., Shou P., Zheng C., Du L., Han X., Jiang M., Yang Q., Lin L., Wang G., Yu P., Zhang X., Cao W., Brewer G., Wang Y., Shi Y., MiR-155 regulates immune modulatory properties of mesenchymal stem cells by targeting TAK1-binding protein 2. The Journal of Biological Chemistry 2013 288 16 11074 11079 2-s2.0-84876584007 10.1074/jbc.M112.414862
173. Hemeda H., Jakob M., Ludwig A.-K., Giebel B., Lang S., Brandau S., Interferon- γ and tumor necrosis factor- α differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells and Development 2010 19 5 693 706 2-s2.0-77952944054 10.1089/scd.2009.0365
174. Ziaei R., Ayatollahi M., Yaghobi R., Sahraeian Z., Zarghami N., Involvement of TNF- α in differential gene expression pattern of CXCR4 on human marrow-derived mesenchymal stem cells. Molecular Biology Reports 2014 41 2 1059 1066
175. Xu J., Wang D., Liu D., Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood 2012 120 15 3142 3151
176. Dorronsoro A., Ferrin I., Salcedo J. M., Human mesenchymal stromal cells modulate T-cell responses through TNF-a-mediated activation of NF- κ B. European Journal of Immunology 2013 44 2 480 488
177. Pistoia V., Raffaghello L., Unveiling the role of TNF- α in mesenchymal stromal cell-mediated immunosuppression. European Journal of Immunology 2014 44 2 352 356
178. Zonca M., Mancheño-Corvo P., Delarosa O., Mañes S., Büscher D., Lombardo E., Planelles L., APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase. Tissue Engineering A 2012 18 7-8 852 859 2-s2.0-84859018505 10.1089/ten.tea.2011.0316
179. Burger D., Dayer J.-M., Palmer G., Gabay C., Is IL-1 a good therapeutic target in the treatment of arthritis? Best Practice and Research: Clinical Rheumatology 2006 20 5 879 896 2-s2.0-33748657833 10.1016/j.berh.2006.06.004 (Pubitemid 44382385)
180. Moresco E. M. Y., LaVine D., Beutler B., Toll-like receptors. Current Biology 2011 21 13 R488 R493 2-s2.0-79960152357 10.1016/j.cub.2011.05.039
181. Hyun H. C., Yong C. B., Jin S. J., Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 2006 24 12 2744 2752 2-s2.0-33845995756 10.1634/stemcells.2006-0189 (Pubitemid 46053012)
182. Pevsner-Fischer M., Morad V., Cohen-Sfady M., Rousso-Noori L., Zanin-Zhorov A., Cohen S., Cohen I. R., Zipori D., Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007 109 4 1422 1432 2-s2.0-33846914143 10.1182/blood-2006-06-028704 (Pubitemid 46239573)
183. Delarosa O., Dalemans W., Lombardo E., Toll-like receptors as modulators of mesenchymal stem cells. Frontiers in Immunology 2012 3, article 182 2-s2.0-84874246720 10.3389/fimmu.2012.00182
184. Liotta F., Angeli R., Cosmi L., Filì L., Manuelli C., Frosali F., Mazzinghi B., Maggi L., Pasini A., Lisi V., Santarlasci V., Consoloni L., Angelotti M. L., Romagnani P., Parronchi P., Krampera M., Maggi E., Romagnani S., Annunziato F., Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing notch signaling. Stem Cells 2008 26 1 279 289 2-s2.0-38349060182 10.1634/stemcells.2007-0454
185. Romieu-Mourez R., François M., Boivin M.-N., Bouchentouf M., Spaner D. E., Galipeau J., Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. The Journal of Immunology 2009 182 12 7963 7973 2-s2.0-67649209791 10.4049/jimmunol.0803864
186. Opitz C. A., Litzenburger U. M., Lutz C., Lanz T. V., Tritschler I., Köppel A., Tolosa E., Hoberg M., Anderl J., Aicher W. K., Weller M., Wick W., Platten M., Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via Interferon-b and protein kinase R. Stem Cells 2009 27 4 909 919 2-s2.0-65649089411 10.1002/stem.7
187. Lei J., Wang Z., Hui D., Yu W., Zhou D., Xia W., Chen C., Zhang Q., Wang Z., Zhang Q., Xiang A. P., Ligation of TLR2 and TLR4 on murine bonTritschler I.e marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity. Cellular Immunology 2011 271 1 147 156 2-s2.0-80052360805 10.1016/j.cellimm.2011.06.014
188. Raicevic G., Rouas R., Najar M., Stordeur P., Id Boufker H., Bron D., Martiat P., Goldman M., Nevessignsky M. T., Lagneaux L., Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Human Immunology 2010 71 3 235 244 2-s2.0-76949094176 10.1016/j.humimm.2009.12.005
189. Tomic S., Djokic J., Vasilijic S., Vucevic D., Todorovic V., Supic G., Colic M., Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists. Stem Cells and Development 2011 20 4 695 708 2-s2.0-79953680762 10.1089/scd.2010.0145
190. Berk L. C. J. V. D., Jansen B. J. H., Siebers-Vermeulen K. G. C., Netea M. G., Latuhihin T., Bergevoet S., Raymakers R. A., Kögler G., Figdor C. C., Adema G. J., Torensma R., Toll-like receptor triggering in cord blood mesenchymal stem cells. Journal of Cellular and Molecular Medicine B 2009 13 9 3415 3426 2-s2.0-70350453471 10.1111/j.1582-4934.2009.00653.x